The study describes how oncolytic virotherapy can work with existing immunotherapy techniques, boosting the immune capacity to effectively target and destroy cancer cells. A new study by researchers at Arizona State University, US describes how a combination of immunotherapy and virotherapy, using myxoma virus, provides new hope for patients with treatment resistant cancers. The research, recently…
Read more
Combining immunotherapy and virotherapy shows promise for treatment-resistant cancers





